Kon-Kiki Pharma ApS: Financial statements 2025
CVR: 43311824
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Kon-Kiki Pharma ApS (CVR 43311824) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,539,454 and a net result of DKK 419,959 compared with DKK 503,219 the year before. That is an increase of 3.7% compared with the year before. Equity in the 2025 report amounted to DKK 460,450. The solvency ratio was 54.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,539,454
- Profit/Loss
- DKK 419,959
- Equity
- DKK 460,450
- Total Assets
- DKK 838,552
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.5M | 420K | 460K | 1 |
| 2024 | - | 1.5M | 503K | 559K | 1 |
| 2023 | - | 1.7M | 603K | 706K | 1 |
Official annual report
How creditworthy is Kon-Kiki Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Kon-Kiki Pharma ApS has published its annual report for 2024. Gross profit came to DKK 1,484,454, and the net result was DKK 503,219.
About Kon-Kiki Pharma ApS
Kon-Kiki Pharma ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kiki Atting Andersen. The company is owned by Kiki Andersen Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,539,454 and a net result of DKK 419,959 compared with DKK 503,219 the year before. Equity in the 2025 report amounted to DKK 460,450.